Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rotenone is a naturally occurring isoflavone compound extracted from the roots and stems of several tropical and subtropical plants in the Fabaceae family, such as Derris elliptica and Lonchocarpus species. It has been used since the 19th century as a botanical insecticide and piscicide for pest control in agriculture, home gardens, pet care (lice/tick control), and water body management to eradicate fish. Rotenone acts by inhibiting mitochondrial complex I (NADH: ubiquinone oxidoreductase) in the electron transport chain. This blocks electron transfer from iron-sulfur centers to ubiquinone (CoQ), disrupting ATP production and increasing reactive oxygen species that can damage cellular components[2][6][8]. Rotenone also inhibits microtubule assembly. In biomedical research, it is widely used to model Parkinson’s disease due to its neurotoxic effects on dopaminergic neurons[5][6][8]. Rotenone is highly toxic via oral or inhalation exposure; its use as a pesticide is restricted in many countries due to health concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rotenone.